{
    "clinical_study": {
        "@rank": "58606", 
        "arm_group": [
            {
                "arm_group_label": "pemetrexed", 
                "arm_group_type": "Active Comparator", 
                "description": "pemetrexed"
            }, 
            {
                "arm_group_label": "gefitinib", 
                "arm_group_type": "Active Comparator", 
                "description": "gefitinib"
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the efficacy of gefitinib versus pemetrexed as second-line chemotherapy for\n      patients with previous treated non-small cell lung cancer"
        }, 
        "brief_title": "Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Previous Treated Metastatic Non-small Cell Lung Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Cells pathologically diagnosed as histological or radical surgery or     radiation\n             therapy is not possible stage IIIB and stage IV non-small-cell lung cancer patients\n\n          -  second line\n\n          -  ECOG 0\uff5e2\n\n          -  Patients with normal liver function and renal function\n\n        Exclusion Criteria:\n\n          -  Patients with severe acute infection requiring antibiotic therapy\n\n          -  Patients who have received treatment in other areas of cancer within 5 years\n\n          -  During pregnancy and lactation patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "116", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01783834", 
            "org_study_id": "2008-GIRBA-1739"
        }, 
        "intervention": [
            {
                "arm_group_label": "gefitinib", 
                "intervention_name": "Gefitinib", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "pemetrexed", 
                "intervention_name": "Pemetrexed", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Pemetrexed", 
                "Gefitinib"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pemetrexed", 
            "Gefitinib", 
            "iressa", 
            "alimta"
        ], 
        "lastchanged_date": "August 19, 2013", 
        "location": {
            "contact": {
                "email": "hkahn@gilhospital.com", 
                "last_name": "HeeKyung Ahn, professor", 
                "phone": "+82-32-460-2625"
            }, 
            "facility": {
                "address": {
                    "city": "Incheon", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Gachon university Gil Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "other_outcome": {
            "measure": "Number of participants with adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "5years"
        }, 
        "overall_contact": {
            "email": "hkahn@gilhospital.com", 
            "last_name": "Hee Kyung Ahn, professor", 
            "phone": "+82-32-460-2625"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Overall response rate", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01783834"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Gachon University Gil Medical Center", 
            "investigator_full_name": "Eun Kyung Cho", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Progression free survival", 
            "safety_issue": "No", 
            "time_frame": "5years"
        }, 
        "source": "Gachon University Gil Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gachon University Gil Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}